Cargando…
The Serum Ferritin Level Is Associated with the Treatment Responsivity for Rapidly Progressive Interstitial Lung Disease with Amyopathic Dermatomyositis, Irrespective of the Anti-MDA5 Antibody Level
We report the case of a 61-year-old woman with rapidly progressive interstitial lung disease caused by clinically amyopathic dermatomyositis. Both the serum ferritin and anti-melanoma differentiation-associated gene 5 (MDA5) antibody levels were elevated at the time of admission. Despite intensive t...
Autores principales: | Osawa, Takeshi, Morimoto, Kozo, Sasaki, Yuka, Matsuda, Shuichi, Yamana, Kazunari, Yano, Ryozo, Uchiyama, Takashi, Goto, Hajime |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5827321/ https://www.ncbi.nlm.nih.gov/pubmed/29093381 http://dx.doi.org/10.2169/internalmedicine.8335-16 |
Ejemplares similares
-
Pneumomediastinum in MDA5-associated clinically amyopathic dermatomyositis
por: Kotsiou, Ourania S., et al.
Publicado: (2017) -
Anti-MDA5 Amyopathic Dermatomyositis—A Diagnostic and Therapeutic Challenge
por: Bobirca, Anca, et al.
Publicado: (2022) -
Painless Panniculitis upon the Treatment of Clinically Amyopathic Dermatomyositis with Anti-MDA5 Antibody
por: Kishida, Dai, et al.
Publicado: (2021) -
Panniculitis associated with amyopathic dermatomyositis
por: Azevedo, Paula de Oliveira, et al.
Publicado: (2018) -
Pruritus in patients with amyopathic dermatomyositis
por: Poddighe, Dimitri, et al.
Publicado: (2019)